Search - tctmd.com

Displaying 1 - 20 of 60

Sort: Relevancy | Date

The Biggest News of 2022: TCTMD’s Top 10

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

December 30, 2022

Reduction in BP Drives Treatment Preference for Hypertensive Patients

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

December 02, 2022

TCTMD’s Top 10 Most Popular Stories for November 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2022

December 01, 2022

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

November 09, 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

November 07, 2022

Extreme BP-Lowering Harmful After Stroke Thrombectomy: ENCHANTED2/MT

News Daily News

Extreme BP-Lowering Harmful After Stroke Thrombectomy: ENCHANTED2/MT

November 01, 2022

Stroke Thrombectomy May Work for Large Infarcts in the Late Time Window

News Daily News

Stroke Thrombectomy May Work for Large Infarcts in the Late Time Window

October 20, 2022

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

News Daily News

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

October 19, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

Two RCTs Add Needed Evidence for Thrombectomy in Basilar Occlusion

News Daily News

Two RCTs Add Needed Evidence for Thrombectomy in Basilar Occlusion

October 13, 2022

State-of-the-Art Lecture: Future Device Therapies in PE

Presentation TCT 2022

State-of-the-Art Lecture: Future Device Therapies in PE

Presenter: Robert Lookstein

September 19, 2022

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Conclusion

Presentation TCT 2022

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Conclusion

Presenter: Sanjum Sethi

September 19, 2022

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

Presentation TCT 2022

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

Presenter: Eric Secemsky

September 19, 2022

Large Bore Thrombectomy: Are We Any Closer to Understanding Which Device Is Best?

Presentation TCT 2022

Large Bore Thrombectomy: Are We Any Closer to Understanding Which Device Is Best?

Presenter: Catalin Toma

September 19, 2022

CDT: New Devices, Drugs, and Duration?

Presentation TCT 2022

CDT: New Devices, Drugs, and Duration?

Presenter: Andrew Sharp

September 19, 2022

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Intro

Presentation TCT 2022

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Intro

Presenter: Sanjum Sethi

September 19, 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

TCT 832: Aspiration Thrombectomy: a Potential Treatment for Pulmonary Embolism in COVID-19

Presentation TCT 2022

TCT 832: Aspiration Thrombectomy: a Potential Treatment for Pulmonary Embolism in COVID-19

Presenter: Saahil Jumkhawala

September 18, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.